Leaflet: information for the user
Levofloxacino Almus 500 mg film-coated tablets EFG
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
Levofloxacino belongs to a group of medicines called antibiotics. Levofloxacino is a quinolone, a type of antibacterial (antibiotic) with bactericidal activity.
Antibiotics are used to treat bacterial infections and do not work for viral infections such as the flu or a cold.
It is essential to follow the instructions regarding the dose, administration interval, and treatment duration indicated by your doctor.
Do not store or reuse this medication. If you have leftover antibiotic after treatment, return it to the pharmacy for proper disposal. Do not dispose of the medication through the drain or in the trash.
Levofloxacino Almus can be used to treat infections of:
In certain special situations, Levofloxacino Almus may be used to reduce the likelihood of acquiring a type of lung infection called anthrax or a worsening of the disease after exposure to the anthrax-causing bacteria.
Do not take Levofloxacino Almus
The signs of an allergic reaction include: skin rash, difficulty swallowing or breathing, swelling of your lips, face, throat, or tongue.
Do not use this medication if any of the above cases apply to you. If in doubt, consult your doctor, nurse, or pharmacist before using this medication.
Warnings and precautions
Before starting to take this medication
You should not take fluoroquinolone or quinolone antibacterial medications, including Levofloxacino Almus, if you have had a severe reaction to a quinolone or fluoroquinolone in the past. If this is your case, you should inform your doctor as soon as possible.
Consult your doctor or pharmacist before taking your medication:
During treatment with this medication
You may be at increased risk if you are receiving systemic corticosteroid treatment.
In rare cases, you may experience:joint pain and swelling, and inflammation or rupture of tendons. The risk is higher if you are an older person (over 60 years), have received an organ transplant, have kidney problems, or are being treated with corticosteroids. Tendon inflammation and rupture can occur in the first 48 hours of treatment and even several months after stopping treatment with Levofloxacino Almus. At the first sign of tendon pain or inflammation (e.g., in the ankle, wrist, elbow, shoulder, or knee), stop taking Levofloxacino Almus, contact your doctor, and keep the affected area at rest. Avoid any unnecessary exercise, as this may increase the risk of tendon rupture.
In rare cases, you may experience symptoms ofnerve damage (neuropathy), such as pain, burning, tingling, numbness, and/or weakness, especially in your feet and legs or hands and arms. If this happens, stop taking Levofloxacino Almus and inform your doctor immediately to prevent the development of a potentially irreversible disorder.
Severe, prolonged, and potentially irreversible effects
Fluoroquinolone or quinolone antibacterial medications, including Levofloxacino Almus, have been associated with rare but severe adverse effects, some of which have been of long duration (persistent for months or years), incapacitating, or potentially irreversible. This includes tendon pain, muscle pain, and joint pain in the upper and lower extremities, difficulty walking, abnormal sensations such as pinpricks, tingling, numbness, or burning (paresthesia), sensory disorders such as decreased vision, taste, smell, and hearing, depression, decreased memory, intense fatigue, and severe sleep disorders.
If you experience any of these adverse effects after taking Levofloxacino Almus, contact your doctor immediately before continuing treatment. You and your doctor will decide whether to continue or not the treatment, also considering the use of an antibiotic of another class.
Inform your doctor, nurse, or pharmacist before using Levofloxacino Almus if you are unsure whether any of the above cases applies to you.
Severe skin reactions
Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported with the use of levofloxacino.
If you develop a severe skin rash or any of these skin symptoms, stop taking levofloxacino and contact your doctor or seek medical attention immediately.
Taking Levofloxacino Almus with other medications
Inform your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription.
Levofloxacino Almus may interact with other medications in terms of their action and vice versa.
Inform your doctor if you are taking any of the following medications. This is because it may increase the likelihood of you experiencing adverse effects when taken with Levofloxacino Almus:
Do not take Levofloxacino Almus at the same time as the following medications. This is because it may affect the action of Levofloxacino Almus:
Determination of opiates in urine
Urine tests may give "false positives" for strong painkillers called "opioids" in people taking Levofloxacino Almus. If your doctor has prescribed a urine test, inform your doctor that you are taking Levofloxacino Almus.
Tuberculosis test
This medication may give "false negatives" for some laboratory tests used to detect the bacteria that causes tuberculosis.
Pregnancy, breastfeeding, and fertility
Consult your doctor or pharmacist before using any medication.
Do not take this medication:
If you are pregnant, could be pregnant, or think you may be pregnant.
If you are breastfeeding or plan to be.
Driving and operating machinery
Due to the possibility of developing some adverse effects such as dizziness, drowsiness, balance disturbances (vertigo), or visual disturbances. Some of these adverse effects may affect your ability to concentrate or decrease your reaction time. If this occurs, do not drive or perform any work that requires high attention.
Levofloxacino Almus contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
How to take this medication
Protect your skin from the sun
Do not take direct sun or UV radiation while taking this medication and for 2 days after stopping it. This is because your skin will become much more sensitive to the sun and may cause severe burns, tingling, or blisters if you do not take the following precautions:
If you are taking iron, zinc supplements, antacids, didanosine, or sucralfate
What dose should you take
Adults and elderly people
Sinusitis (paranasal sinus infection)
1 tablet once a day
Pulmonary infection, in people with long-term respiratory problems
1 tablet once a day
Pneumonia
1 tablet once or twice a day
Urinary tract infection, including the kidneys or bladder
Half or 1 tablet a day
Prostate infection
1 tablet once a day
Skin and subcutaneous tissue infection, including muscles
1 tablet once or twice a day
Adults and elderly people with kidney problems
Your doctor may possibly administer a lower dose.
Children and adolescents
This medication should not be administered to children or adolescents.
If you take more Levofloxacino Almus than you should
The symptoms of levofloxacin overdose may be: dizziness, confusion, tremors, altered consciousness, and seizures, and heart disturbances that may cause abnormal heart rhythm, as well as discomfort (nausea) or stomach burning. Your doctor will apply the usual measures to eliminate the non-absorbed drug. Your treatment will depend on your symptoms. An ECG monitoring should be performed. Levofloxacin is not eliminated from the body through dialysis. There is no specific antidote.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or call the Toxicological Information Service, phone 91 562 04 20 (indicating the medication and the amount ingested).
If you forgot to take Levofloxacino Almus
If you forgot to take your dose at the right time, take it as soon as possible, and then continue with your usual dosing schedule. Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Levofloxacino Almus
Do not stop taking Levofloxacino Almus just because you feel better. It is essential that you complete the treatment prescribed by your doctor personally. If you stop taking the tablets too soon, the infection may recur, your condition may worsen, or the bacteria may become resistant to the medication.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Levofloxacino Almus can cause side effects, although not everyone will experience them.
Stop taking Levofloxacino Almus and consult a doctor or go to the hospital immediately if you notice the following side effects:
Very rare(may affect up to 1 in 10,000 patients)
Stop taking Levofloxacino Almus and see a doctor immediately if you notice any of the following serious side effects - you may need urgent medical treatment:
Rare(may affect up to 1 in 1,000 patients)
Very rare(may affect up to 1 in 10,000 patients)
Not known(the frequency cannot be estimated from the available data)
If your vision worsens or if you have any eye changes while taking Levofloxacino Almus, see an ophthalmologist immediately.
Inform your doctor if any of the following side effects worsen or last more than a few days:
Common(may affect up to 1 in 10 patients)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 patients)
Frequency not known(cannot be estimated from the available data)
The administration of antibiotics containing quinolones and fluoroquinolones has been associated with very rare cases of long-lasting or permanent adverse reactions (even months or years) such as tendon inflammation, tendon rupture, joint pain, limb pain, difficulty walking, abnormal sensations such as pinching, numbness, tingling, burning, or pain (neuropathy), depression, fatigue, sleep disorders, memory loss, and hearing, vision, taste, and smell loss, in some cases regardless of the presence of pre-existing risk factors.
Cases of aortic aneurysm and dissection, which could lead to rupture and be fatal, and heart valve insufficiency in patients who have received fluoroquinolones have been reported. See also section 2.
If you experience side effects, consult your doctor or pharmacist, even if they are side effects that do not appear in this leaflet.
Reporting of side effects
If you experience any type of side effect, consult your doctor, nurse, or pharmacist, even if it is possible side effects that do not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicinal Products for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Levofloxacino Almus
The active ingredient of Levofloxacino Almus 500 mg tablets EFG is levofloxacin. Each tablet contains 500 mg of levofloxacin.
The other components are:Core: microcrystalline cellulose, hydroxypropyl methylcellulose, crospovidone, sodium fumarate stearate.Coating (Opadry 03B27148 Beige): 6cP hypromellose, titanium dioxide, polyethylene glycol 400, talc, yellow iron oxide, red iron oxide, black iron oxide.
Appearance of the product and contents of the packaging
Levofloxacino Almus is presented in the form of coated tablets. The tablets are oblong with a yellowish core and a light pink coating, scored on one face.
Each package contains 7 or 14 tablets in a blister pack. It is possible that not all presentations are marketed.
Holder of the marketing authorization and responsible manufacturer
Holder of the marketing authorization:
Almus Farmacéutica, S.A.U.
Marie Curie, 54
08840 Viladecans (Barcelona), Spain
Phone: 93 739 71 80
Email: [email protected]
Responsible manufacturer:
Medinfar Manufacturing, S.A.
Parque Industrial Armando Martins Tavares,
Rua Outeiro da Armada, 5, Condeixa-a-Nova
3150-194 Sebal
Portugal
Last review date of this leaflet: September 2024
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.